High cytoplasm HABP1 expression as a predictor of poor survival and late tumor stage in pancreatic ductal adenocarcinoma patients
ConclusionHigh cytoplasm HABP1 expression may prove to be a predictor of poor survival and late tumor stage in PDAC patients. HABP1 could serve as a promising biomarker to identify subsets of PDAC patients with high malignant clinical behavior.
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
More News: Adenocarcinoma | Cancer & Oncology | Carbohydrates | Pancreas | Pancreatic Cancer | Study | Surgery